Kiniksa Pharmaceuticals International Insider Sold Shares Worth $14,330,278, According to a Recent SEC Filing

MT newswire2026/11/06 20:59

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:59 PM EST, 11/06/2026 (MT Newswires) -- Sanj K Patel, Director, Chairman & CEO, on November 04, 2026, sold 151,300 shares in Kiniksa Pharmaceuticals International (KNSA) for $14,330,278. Following the Form 4 filing with the SEC, Patel has control over a total of 976,643 Class A ordinary shares of the company, with 976,643 controlled indirectly. Sales were effected pursuant to a 10b5-1 plan executed by the reporting person on July 30. SEC Filing: https://www.sec.gov/Archives/edgar/data/1730430/000153221826000020/xslF345X05/form4-11062026_091108.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $14,330,278, According to a Recent SEC Filing

You may also like

Crypto prices